Insider Trading activities of Pfenex Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pfenex Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pfenex Inc. since year 2005. Table 2 shows the detailed insider transactions of Pfenex Inc. since 2005. The reporting company's ticker symbol is PFNX. The reporting company's CIK number is 1478121.
The total value of stock buying since 2005 is $45,060.
The total value of stock sales since 2005 is $98,147,965.
The total value of stock option exercises since 2005 is $3,720.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Pfenex Inc. (PFNX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-06 10,000 $45,060 0 $0 0 $0
2017-05 0 $0 2,000 $9,568 2,000 $620
2017-01 0 $0 8,110 $77,065 0 $0
2016-12 0 $0 139,600 $1,339,595 0 $0
2016-11 0 $0 7,000 $69,946 2,000 $620
2016-08 0 $0 2,000 $18,836 2,000 $620
2016-05 0 $0 2,000 $13,044 2,000 $620
2015-12 0 $0 608,500 $7,177,439 0 $0
2015-11 0 $0 8,500 $144,800 2,000 $620
2015-10 0 $0 1,500 $22,477 0 $0
2015-09 0 $0 8,500 $179,215 2,000 $620
2015-08 0 $0 6,500 $135,335 0 $0
2015-07 0 $0 6,500 $128,444 0 $0
2015-06 0 $0 6,500 $123,629 0 $0
2015-05 0 $0 6,500 $87,319 0 $0
2015-04 0 $0 6,054,267 $88,220,332 0 $0
2015-03 0 $0 11,500 $164,785 0 $0
2014-07 0 $0 761,734 $236,136 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Pfenex Inc. insiders (PFNX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-06-12 Grenfell-gardner Jason (Director) Buy 10,000 4.51 45,060
2017-05-16 Lady Patricia (Chief Accounting Officer) Sale 2,000 4.78 9,568
2017-05-16 Lady Patricia (Chief Accounting Officer) Option Ex 2,000 .31 620
2017-01-06 Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner) Sale 400 9.50 3,800
2017-01-05 Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner) Sale 1,391 9.51 13,229
2017-01-04 Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner) Sale 6,319 9.50 60,036
2016-12-29 Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner) Sale 2,104 9.65 20,305
2016-12-28 Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner) Sale 22,000 9.66 212,432
2016-12-27 Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner) Sale 27,100 9.67 262,057
2016-12-23 Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner) Sale 77,500 9.55 740,125
2016-12-22 Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner) Sale 1,120 9.58 10,729
2016-12-21 Signet Healthcare Partners Accredited Partnership Iii Lp (10% Owner) Sale 9,776 9.61 93,947
2016-11-21 Lady Patricia (Chief Accounting Officer) Sale 2,000 9.87 19,736
2016-11-21 Lady Patricia (Chief Accounting Officer) Option Ex 2,000 .31 620
2016-11-15 Lucy Patrick K. (Chief Business Officer) Sale 5,000 10.04 50,210
2016-08-18 Lady Patricia (Chief Accounting Officer) Sale 2,000 9.42 18,836
2016-08-18 Lady Patricia (Chief Accounting Officer) Option Ex 2,000 .31 620
2016-05-24 Lady Patricia (Chief Accounting Officer) Sale 2,000 6.52 13,044
2016-05-24 Lady Patricia (Chief Accounting Officer) Option Ex 2,000 .31 620
2015-12-15 Dow Chemical Co /de/ (10% Owner) Sale 600,000 11.75 7,050,000
2015-12-03 Lucy Patrick K. (Chief Business Officer) Sale 1,500 14.15 21,231
2015-12-01 Talbot Henry W. Jr. (VP of Operations) Sale 2,000 15.08 30,168
2015-12-01 Liang Bertrand C. (Chief Executive Officer) Sale 5,000 15.21 76,040
2015-11-18 Lady Patricia (Chief Accounting Officer) Sale 2,000 14.05 28,102
2015-11-18 Lady Patricia (Chief Accounting Officer) Option Ex 2,000 .31 620
2015-11-04 Lucy Patrick K. (Chief Business Officer) Sale 1,500 17.75 26,628
2015-11-02 Liang Bertrand C. (Chief Executive Officer) Sale 5,000 18.01 90,070
2015-10-02 Lucy Patrick K. (Chief Business Officer) Sale 1,500 14.98 22,477
2015-09-03 Lady Patricia (Chief Accounting Officer) Sale 2,000 20.48 40,960
2015-09-03 Lady Patricia (Chief Accounting Officer) Option Ex 2,000 .31 620
2015-09-03 Lucy Patrick K. (Chief Business Officer) Sale 1,500 20.91 31,365
2015-09-01 Liang Bertrand C. (Chief Executive Officer) Sale 5,000 21.38 106,890
2015-08-05 Lucy Patrick K. (Chief Business Officer) Sale 1,500 20.75 31,125
2015-08-03 Liang Bertrand C. (Chief Executive Officer) Sale 5,000 20.84 104,210
2015-07-06 Lucy Patrick K. (Chief Business Officer) Sale 1,500 19.17 28,749
2015-07-01 Liang Bertrand C. (Chief Executive Officer) Sale 5,000 19.94 99,695
2015-06-03 Lucy Patrick K. (Chief Business Officer) Sale 1,500 20.08 30,119
2015-06-01 Liang Bertrand C. (Chief Executive Officer) Sale 5,000 18.70 93,510
2015-05-04 Lucy Patrick K. (Chief Business Officer) Sale 1,500 13.25 19,879
2015-05-01 Liang Bertrand C. (Chief Executive Officer) Sale 5,000 13.49 67,440
2015-04-29 Signet Healthcare Partners Accredited Partnership Iii Lp Sale 1,907,767 14.57 27,796,165
2015-04-29 Gale James C Sale 1,907,767 14.57 27,796,165
2015-04-29 Dow Chemical Co /de/ (10% Owner) Sale 2,232,233 14.57 32,523,634
2015-04-02 Lucy Patrick K. (Chief Business Officer) Sale 1,500 17.62 26,428
2015-04-01 Liang Bertrand C. (Chief Executive Officer) Sale 5,000 15.59 77,940
2015-03-04 Lucy Patrick K. (Chief Business Officer) Sale 1,500 14.36 21,535
2015-03-02 Liang Bertrand C. (Chief Executive Officer) Sale 10,000 14.32 143,250
2014-07-29 Signet Healthcare Partners Qp Partnership Ii Lp (10% Owner) Sale 380,867 .31 118,068
2014-07-29 Gale James C (Director) Sale 380,867 .31 118,068

Insider trading activities including stock purchases, stock sales, and option exercises of PFNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pfenex Inc. (symbol PFNX, CIK number 1478121) see the Securities and Exchange Commission (SEC) website.